title: Hydroxyurea, methotrexate and adriblastine can mediate non-enzymatic reduction of nitroblue tetrazolium with NADH which is inhibited by superoxide dismutase.
authors.affiliation: Department of Biochemistry, Institute of Haematology, Warsaw, Poland.
authors.forename: W M
authors.initials: WM
authors.lastname: Przybyszewski
authors.forename: J
authors.initials: J
authors.lastname: Malec
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D005609:Free Radicals; D006918:Hydroxyurea / Q000494:pharmacology*; D008727:Methotrexate / Q000494:pharmacology*; D009243:NAD / Q000494:pharmacology*; D009580:Nitroblue Tetrazolium / Q000378:metabolism*; D010084:Oxidation-Reduction; D013482:Superoxide Dismutase / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism; D013778:Tetrazolium Salts / Q000378:metabolism*
chemical_list: D000903:Antibiotics, Antineoplastic; D005609:Free Radicals; D013778:Tetrazolium Salts; D009243:NAD; D013481:Superoxides; D009580:Nitroblue Tetrazolium; D004317:Doxorubicin; D013482:Superoxide Dismutase; D006918:Hydroxyurea; D008727:Methotrexate